key: cord-0816800-ki8t36wy
authors: Pisano, Antonio; Yavorovskiy, Andrey; Verniero, Luigi; Landoni, Giovanni
title: Indications for tracheal intubation in COVID-19 patients
date: 2020-12-02
journal: J Cardiothorac Vasc Anesth
DOI: 10.1053/j.jvca.2020.11.062
sha: fbde7a9c5c706b80443f8b927264b2d55b0e3098
doc_id: 816800
cord_uid: ki8t36wy

nan

With more than 53 million cases of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection worldwide (at the time of writing) and the recent new increase in contagions in many countries 1 , the number of patients hospitalized for coronavirus disease 2019 (COVID-19)-related severe acute respiratory infection (SARI) has been exceptionally high.

Despite an extensive reorganization of hospitals 2 to face this unparalleled situation in the modern history of medicine, intensive care unit (ICU) beds shortage remains a major issue, and most of these patients are cared for in the wards, with either oxygen supplementation or noninvasive supports such as continuous positive airway pressure (CPAP) with masks or helmets, high-flow nasal cannulae (HFNC), or noninvasive ventilation (NIV).

Moreover, attending physicians in these wards have sometimes limited experience in acute respiratory failure and oxygen therapy/ventilatory support devices (for this reason, recently published educational papers on noninvasive respiratory support for "re-deployed" hospital doctors and general practitioners can be found in literature 3 In the early stages of the pandemic (or in the less affected areas), cardiothoracic anesthesiologists/intensivists have been involved mainly with regard to the rearrangement of cardiothoracic surgical activity and to the protection of patients and healthcare workers from infection 5,6 , as well as in the management of cardiac complications (myocarditis, pericardial dysfunction and other acute cardiac injuries have been reported in up to 20-30% of hospitalized COVID-19 patients 7,8 ; moreover, SARS-CoV-2 infection may worsen pre-existing heart diseases or lead to sepsis-related cardiomyopathy 9 ). However, due to the significant reduction in the number of elective surgical procedures and to the pressing need for clinicians with airway management and mechanical ventilation skills, most cardiothoracic anesthesiologists/intensivists have been also directly involved in the primary care of patients with COVID-19-related SARI in the areas (or in the periods) with heavier epidemic burden.

In this context, intensivists (and redeployed anesthesiologists) are subjected to continuous requests of consultation, primarily to evaluate the need for tracheal intubation and, accordingly, for ICU admission and invasive mechanical ventilation. This is a rather challenging task. In fact, current guidelines say nothing 8, 10 or are vague, with little adherence to clinical reality, and not based on strong evidence 11 about the indications for tracheal intubation in COVID-19 patients. Moreover, despite a long-standing debate (since the pandemic started) between supporters of "early" vs. "late" tracheal intubation, there is no clear evidence of the superiority of one strategy over the other in terms of outcome. 12 For example, some authors recently claimed about improved results with an "early intubation" protocolized approach in COVID-19 patients 13 , while others raised concerns about a possible patient self-inflicted lung injury (P-SILI) in patients with severe respiratory failure left in spontaneous breath. 14 However, the criteria used for tracheal intubation in this "early intubation protocol" have been heavily criticized 15 , and the observational design of the study does not allow to prove that those patients would have had a worse outcome with a different treatment.

Moreover, the considerations about P-SILI, although very intriguing, are highly speculative and not yet supported by strong evidence (as opposed to the well documented complications of invasive mechanical ventilation). 16 Conversely, other (also observational) studies showed favorable outcomes with long-term noninvasive support (e.g. CPAP with masks or helmets), with or without (awake) pronation. 17, 18 What should be well kept in mind, finally, is that tracheal intubation and invasive mechanical ventilation expose patients to well-established (and, as mentioned, widely documented in the literature) complications such as ventilator-associated pneumonia (VAP) and ventilator-induced lung injury (VILI), in addition to those related to sedation and immobility, all possibly associated with increased mortality: accordingly, the decision to intubate a patient should be taken with extreme caution, and always when the benefits can reasonably be expected to outweigh the risks. 12, 15, 16 All this, of course, must be contextualized in the clinical scenario described above, which comprises the ICU beds shortage on the one hand, and the "anxieties" of the attending physicians in the wards on the other hand.

In our experience, a major concern of colleagues taking care of non-invasively supported COVID-19 patients is the low (<100 mmHg) arterial partial pressure of oxygen (P a O 2 ) to oxygen inspiratory fraction (F I O 2 ) ratio. Indeed, it seems that many clinicians today (probably since the COVID-19 pandemic started) consider "hypoxemia" in terms of the amount of oxygen provided to the patient. 19 Of course, the P a O 2 /F I O 2 ratio is a simple marker of the severity of respiratory failure, in particular of acute respiratory distress syndrome (ARDS), and it has been found to be an independent risk factor for 30-day mortality in a recent large observational cohort study of 10,362 COVID-19 patients (both mechanically ventilated or not) from 258 ICUs. 20 However, the P a O 2 /F I O 2 ratio is not as reliable as the alveolar-to-arterial oxygen gradient as a measure of gas exchange impairment. 21 In fact, it is not independent from the F I O 2 administered and it is also significantly affected by other factors unrelated to the degree of gas exchange compromise such as hemoglobin concentration, the difference between arterial and venous oxygen content, and even (to a lesser extent) barometric pressure (see Figure 1 ). 22 Moreover, the influence of these factors (including the F I O 2 administered) on the P a O 2 /F I O 2 ratio has been found to vary substantially according to the degree of intrapulmonary shunt. 22 Regardless of all this, there is no evidence that using any value of the P a O 2 /F I O 2 ratio as a trigger for tracheal intubation could affect the outcome of patients with COVID-19-related ARDS. Although, in the large cohort study mentioned above, the association between the P a O 2 /F I O 2 ratio (during the first 24 hours after ICU admission) and 30-day mortality was a bit more pronounced in not ventilated patients, thus seemingly suggesting a better outcome in early mechanically ventilated patients, it was not reported if, after how long, and according to which criteria the initially not ventilated patients were subsequently intubated. 20 Most remarkably, ventilated patients with a P a O 2 /F I O 2 ratio 300 mm Hg had an almost doubled 30-day mortality as compared with nonventilated patients (hazard ratio [HR] = 1.89) 20 : this suggests that, in less severe patients, the detrimental effects of invasive mechanical ventilation prevailed over benefits, and may represent an argument against early "preventive" intubation strategies.

It should be also remembered that the P a O 2 /F I O 2 ratio in non-intubated patients undergoing either oxygen supplementation with devices such as nasal cannulae, Venturi masks, and reservoir bag masks or noninvasive ventilatory support with CPAP systems connected to high-flow oxygen can be only roughly estimated: in fact, the F I O 2 delivered to the patient as calculated according to the formulas reported in the literature or the charts provided by manufacturers is only theoretical (and quite reliable under physiological conditions), but it can widely vary according to several factors such as the patient's ventilatory pattern (tidal volume, respiratory rate, respiratory pauses) or the presence of air leaks. 21, 23, 24 Accordingly, the actual P a O 2 /F I O 2 ratio can be often underestimated (since the F I O 2 delivered is overestimated) in non-intubated patients.

Maybe, absolute P a O 2 and, even more, the resulting oxygen arterial saturation (S a O 2 ), are much more important. Ultimately, as shown in Figure 2 , S a O 2 (not P a O 2 ) is the major "respiratory" determinant of oxygen delivery and, according to the well-known factors affecting the O 2hemoglobin dissociation curve, a P a O 2 between 50 and 60 mmHg may correspond to an acceptable S a O 2 ( 90-92%). [19] [20] [21] As an (extreme) example, a patient with a P a O 2 around 60 mmHg may have an S a O 2 > 91% in conditions of normothermia, but a much lower S a O 2 if he/she has a high fever (see Figure 2 ) 19 : accordingly, administering an antipyretic may even prevent him/her from tracheal intubation. Clinicians should be also advised to always rely on S a O 2 values measured by blood gas analysis rather than on pulse oximetry: the latter, in fact, only provides an estimation of S a O 2 , with well-known limitations. 21, 25 Finally, what tells us which S a O 2 (or P a O 2 ) is "acceptable" is also the evaluation of signs and symptoms of significant respiratory distress or tissue hypoxia (e.g. respiratory rate above 25-30 min -1 , sweating, dyspnea, tachycardia, increased blood lactate levels, etc.). In the absence of severe absolute hypoxemia (usually defined as a P a O 2 < 50 mmHg) and of the above-mentioned signs and symptoms, and with a patient who tolerates well the ongoing noninvasive support, does it matter how much oxygen do you need to provide him/her (even assuming to be able to calculate it accurately) to obtain such a "stability", or how much severe is his/her disease? In this regard, not even the radiological severity of the COVID-19-related pneumonia should be considered per se as a criterion for tracheal intubation, despite the potentially misleading titles of some retrospective studies which, rather predictably, found an association between worst initial chest computed tomography findings and the risk of subsequent need for tracheal intubation, invasive mechanical ventilation, or ICU admission. 26, 27 In summary (see also Ultimately, if I leave an awake and cooperative COVID-19 patient in the ward with a CPAP mask with the maximum F I O 2 allowed (which will probably be much lower than 1.0 whatever the mask instructions and charts say), a compensated blood gas analysis with a P a O 2 above 50 or 60 mmHg (whatever the estimated P a O 2 /F I O 2 ratio), normal lactate levels, and an acceptable respiratory rate, it should be because this is probably the best choice at the moment, and not because there is no ICU beds availability. Figure 1 The P a O 2 /F I O 2 ratio has important limitations both as a marker of the severity of pulmonary gas exchange impairment and, even more, as a criterion to justify tracheal intubation in patients with COVID-19-related SARI/ARDS. O 2 Hb, oxyhemoglobin; P a O 2 , partial pressure of oxygen; S a O 2 , arterial oxygen saturation; F I O 2 , inspiratory oxygen fraction; Q S /Q T , intrapulmonary shunt fraction; C a-v O 2 , difference between arterial and venous oxygen content; BE, base excess; P a CO 2 , partial pressure of carbon dioxide 

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard

Fast reshaping of intensive care unit facilities in a large metropolitan

Respiratory failure and non-invasive respiratory support during the covid-19 pandemic: an update for re-deployed hospital doctors and primary care physicians

European Society of Intensive Care Medicine (ESICM) Academy website. Covid-19 Skills PrepAration CoursE (C-19 SPACE) training

Protecting high-risk cardiac patients during the COVID-19 Outbreak

Cardiothoracic Surgery at the Time of the Coronavirus Disease-2019 Pandemic: Lessons From the East (and From a Previous Epidemic) for Western Battlefields

COVID-19 and the Heart

COVID-19) treatment guidelines

COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

Resuscitation and Intensive Care (SIAARTI) recommendations on the management of the critically ill Coronavirus Disease 2019 (COVID-19) patient

Early versus late tracheal intubation in COVID-19 patients: a pro-con debate also considering heart-lung interactions

A prospective, observational, cohort study of airway management of patients with COVID-19 by specialist tracheal intubation teams

Management of COVID-19 respiratory distress

The criteria used to justify endotracheal intubation of patients with COVID-19 are worrisome

Caution about early intubation and mechanical ventilation in COVID-19

Continuous positive airway pressure and pronation outside the intensive care unit in COVID 19 ARDS

Awake pronation with helmet continuous positive airway pressure for COVID-19 acute respiratory distress syndrome patients outside the ICU: A case series

Why COVID-19 Silent Hypoxemia Is Baffling to Physicians

ICNARC COVID-19 Team

Prognostic Factors for 30-Day Mortality in Critically Ill Patients With Coronavirus Disease 2019: An Observational Cohort Study

Basing Respiratory Management of COVID-19 on Physiological Principles

Evaluating Pulmonary Function: An Assessment of PaO2/FIO2

Reliability of methods to estimate the fraction of inspired oxygen in patients with acute respiratory failure breathing through non-rebreather reservoir bag oxygen mask

Performance of six types of oxygen delivery devices at varying respiratory rates

Air Pollution, and Pulse Oximetry: The Beer-Lambert Law

Diagnostic Value of Initial Chest CT Findings for the Need of ICU Treatment/Intubation in Patients with COVID-19

Quantitative chest CT analysis in COVID-19 to predict the need for oxygenation support and intubation

Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers

Figure 2 The partial pressure of oxygen (P a O 2 ) provides a negligible direct contribution to oxygen delivery

Hb) dissociation curve. The O 2 Hb dissociation curve, in turn, is affected by several factors such as pH, partial pressure of carbon dioxide (P a CO 2 ), and temperature (T°C)